Cryptolepis 0.7 milliliter by Ortho Molecular Products

This fits adults working with a clinician on a botanical antimicrobial plan who want a single-herb cryptolepis tincture rather than a blend. It’s commonly used when microbial balance is the goal and your hs-CRP (an inflammation marker) runs high during flares. If you’ve had liver enzyme bumps before, build in checks of ALT and AST (liver enzymes) during use. Many practitioners pair cryptolepis with cat’s claw or Japanese knotweed when the Omega-3 Index is fine but infection-driven symptoms are suspected.

Cryptolepis (Cryptolepis sanguinolenta) contains indoloquinoline alkaloids like cryptolepine that, in lab studies, disrupt microbial DNA handling and break down biofilms (the protective layers some microbes form). That’s why it shows in‑vitro activity against certain bacteria and protozoa, including Borrelia species and malaria parasites. It also has polyphenols with modest antioxidant effects. Human data are limited to small and uncontrolled studies, so treat this as a clinician-guided experiment and track symptoms with labs like hs-CRP rather than expecting drug-like results.

Mix one full dropper (about 0.7 mL) in a few ounces of water twice daily, as directed. The taste is bitter; food can help if your stomach is sensitive. Many clinicians start at half-dropper doses for 3–5 days, then increase to the suggested use. Reassess within 4 to 6 weeks with your symptom log and, if relevant, hs-CRP or a Liver Panel. If you need multi-herb coverage, practitioners often add Andrographis or Sweet Wormwood rather than pushing this higher.

Skip during pregnancy or while trying to conceive; traditional texts note uterine effects. Avoid if you have active liver disease, heavy alcohol use, or a history of unexplained ALT/AST elevations; monitor a Liver Panel if you proceed. Data on drug interactions are sparse, so use extra caution with narrow-therapeutic-index drugs (warfarin, digoxin, tacrolimus) and other liver-metabolized agents. If you’re already on antibiotics, do not stop them; some clinicians combine cryptolepis, but that decision should be supervised.